Organigram Global (OGI) Assets Average (2019 - 2026)
Organigram Global (OGI) posted quarterly Assets Average of $380.3 million for Q1 2026, down 3.6% on a QoQ basis from $394.5 million in Q4 2025.
Organigram Global (OGI) Assets Average (2019 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Assets Average for 7 consecutive years, with $380.3 million the latest figure, recorded in Q1 2026.
- Quarterly Assets Average changed N/A year-over-year to $380.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $380.3 million (changed N/A YoY) and the FY2025 annual result came in at $394.5 million, changed N/A from the prior year.
- Assets Average declined to $380.3 million in Q1 2026 per OGI's latest filing, from $394.5 million in the prior quarter.
- Over the last five years, Assets Average for OGI reached as high as $394.5 million in Q4 2025 and fell as low as $260.8 million in Q3 2024.
- A 4-year average of $342.8 million and a median of $357.9 million in 2023 frame the typical range for Assets Average.
- The largest YoY upside for Assets Average was 22.24% in 2024 against a maximum downside of 22.24% in 2024.
- Year by year, Assets Average stood at $335.4 million in 2023, then decreased by 22.24% to $260.8 million in 2024, then soared by 51.27% to $394.5 million in 2025, then fell by 3.6% to $380.3 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $380.3 million, $394.5 million, and $260.8 million for Q1 2026, Q4 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 380.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380.34 Mn |
| Dec 31, 2025 | 394.53 Mn |
| Sep 30, 2024 | 260.80 Mn |
| Sep 30, 2023 | 335.38 Mn |
| Feb 28, 2021 | 433.07 Mn |
| Nov 30, 2020 | 398.59 Mn |
| Aug 31, 2020 | 316.97 Mn |
| May 31, 2020 | 406.20 Mn |
| Aug 31, 2019 | 376.06 Mn |